FACS analyses to assess fusion cells demonstrated that DCs expressed CD11c molecules and were negative for Muc-1 tumor antigen, whereas MDA-MB-231 expressed Muc-1 tumor antigens and were negative for CD11c molecule. This evidence concerns the gene ITGAX and neoplasm.